In Treatment of Bacterial infections Moxgrey 625 LB Tablet is used to treat and control different infections caused by bacteria, such as sinusitis, pneumonia, ear infections, bronchitis, urinary tract infections, and infections of the skin. It works by killing the bacteria causing infections in the body. Make sure to complete the full course of treatment. This will ensure that the infection is completely cured and prevent it from returning.
It is not known whether it is safe to consume alcohol with Moxgrey 625 LB Tablet. Please consult your doctor.
Information regarding the use of Moxgrey 625 LB Tablet during pregnancy is not available. Please consult your doctor.
Moxgrey 625 LB Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Moxgrey 625 LB Tablet may cause side effects which could affect your ability to drive. Moxgrey 625 LB Tablet can have side effects and the symptoms (such as allergic reactions, dizziness and convulsions) may make you unfit to drive.
Moxgrey 625 LB Tablet should be used with caution in patients with kidney disease. Dose adjustment of Moxgrey 625 LB Tablet may be needed. Please consult your doctor. Use of this medicine is not recommended in patients with severe kidney disease.
Moxgrey 625 LB Tablet should be used with caution in patients with liver disease. Dose adjustment of Moxgrey 625 LB Tablet may be needed. Please consult your doctor. Regular monitoring of liver function tests is advised while you are taking this medicine.
If you miss a dose of Moxgrey 625 LB Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Woakes Pharma || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Hebert Biotech || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Stallion Laboratories Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Wyupharama || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Chemo Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sarian Healthcare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Iva Healthcare Pvt. Ltd. || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Betlif Pharmaceutical Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Axis Life Science Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Maxolus Pharmaceuticals || ₹14.5/tablet (25% cheaper)